2026 Market Access Trends Archives

Market Access Trends 2026

How MFN and Direct-to-Consumer Models Are Rewiring US Market Access

March 23, 2026

Globally, 2025 marked a shift from debating drug pricing policy to implementing it. Pricing pressure intensified, evidence expectations rose, and long-standing access models began to change amid political and fiscal realities. In Trinity’s webinar “Around the World in Market Access 2026:...

Market Access Trends 2026

How Regulatory–HTA Convergence Is Reshaping European Market Access

March 24, 2026

Across Europe, 2025 accelerated a shift from sequential regulatory and access steps to more connected process through the Joint Clinical Assessment. Regulatory approvals, and clinical portion of HTA evaluation are now more tightly linked, which has the potential to bring the...

Market Access Trends 2026

How Four Pillars Are Shaping Latin America and MENA Market Access

March 25, 2026

Latin American and MENA markets have long faced the challenge of balancing constrained public budgets with rising demand for newer therapies. In 2025, governments in these regions took concrete steps to modernize pricing rules, raise evidence expectations, expand partnership models, and...

Market Access Trends 2026

How China’s Layered Access System and Real-World Evidence Are Changing Market Access

March 26, 2026

China is evolving beyond a single public reimbursement model toward a layered access system that combines national coverage, commercial funding, and early access programs. In 2025, these changes began to reshape how manufacturers think about pricing, evidence, and launch sequencing. In...